Peyto (OTCPK:PEYUF) is a Canadian E&P company whose production profile is dominated by dry gas (92%). With the low price of natural gas, it has been a tough couple of years for Peyto’s shareholders. That said, the company has maintained its dividend payout through the commodity price downturn. Recently natural gas prices have recovered from their lows, but Peyto’s stock has not kept pace. In fact, it’s gone the other direction:
Click to enlarge
As the chart above show, the stock is down ~13% over the past three months as natural gas – as measure by both the Henry Hub and AECO indexes – has rallied sharply with significant winter withdrawals and forecasts that additional cold weather is on the way:
Hot Low Price Stocks To Invest In Right Now: Rayonier Advanced Materials Inc.(RYAM)
Advisors’ Opinion:
- [By Joseph Griffin]
Shares of Rayonier Advanced Materials Inc (NYSE:RYAM) have received an average rating of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have covered the stock in the last year is $23.00.
- [By Max Byerly]
Rhumbline Advisers lifted its holdings in shares of Rayonier Advanced Materials Inc (NYSE:RYAM) by 6.8% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 125,460 shares of the basic materials company’s stock after buying an additional 7,982 shares during the period. Rhumbline Advisers’ holdings in Rayonier Advanced Materials were worth $2,144,000 at the end of the most recent reporting period.
- [By Motley Fool Transcriber]
Rayonier Advanced Materials Inc (NYSE:RYAM)Q4 2018 Earnings Conference CallFeb. 14, 2019, 10:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Joseph Griffin]
Shares of Rayonier Advanced Materials Inc (NYSE:RYAM) have earned an average rating of “Buy” from the seven research firms that are presently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $23.25.
- [By Stephan Byrd]
Navellier & Associates Inc boosted its position in shares of Rayonier Advanced Materials Inc (NYSE:RYAM) by 54.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 85,071 shares of the basic materials company’s stock after acquiring an additional 30,036 shares during the period. Navellier & Associates Inc’s holdings in Rayonier Advanced Materials were worth $1,454,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Joseph Griffin]
American International Group Inc. trimmed its position in Rayonier Advanced Materials Inc (NYSE:RYAM) by 9.8% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 31,718 shares of the basic materials company’s stock after selling 3,455 shares during the period. American International Group Inc.’s holdings in Rayonier Advanced Materials were worth $681,000 as of its most recent filing with the SEC.
Hot Low Price Stocks To Invest In Right Now: Orthofix International N.V.(OFIX)
Advisors’ Opinion:
- [By Ethan Ryder]
Factorial Partners LLC increased its position in shares of Orthofix International NV (NASDAQ:OFIX) by 74.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,200 shares of the medical device company’s stock after purchasing an additional 6,500 shares during the period. Factorial Partners LLC owned 0.08% of Orthofix International worth $864,000 at the end of the most recent quarter.
- [By Max Byerly]
Orthofix Medical Inc (NASDAQ:OFIX) has been given an average recommendation of “Buy” by the eight ratings firms that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $63.00.
Hot Low Price Stocks To Invest In Right Now: Microvision Inc.(MVIS)
Advisors’ Opinion:
- [By Max Byerly]
IMPINJ (NASDAQ: PI) and MicroVision (NASDAQ:MVIS) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Microvision (MVIS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Get a free copy of the Zacks research report on Microvision (MVIS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Low Price Stocks To Invest In Right Now: Neptune Technologies & Bioresources Inc(NEPT)
Advisors’ Opinion:
- [By Motley Fool Transcribing]
Neptune Technologies (NASDAQ:NEPT) Q3 2019 Earnings Conference CallFeb. 13, 2019 5:00 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By William Romov]
…or take a chance at 207% returns in just 49 days with penny stocks like Neptune Technologies & Bioressources Inc. (Nasdaq: NEPT)…
…by the end of this step-by-step guide, you’ll know exactly how to do either on Ally’s discount online brokerage platform.
- [By Max Byerly]
Here are some of the media stories that may have impacted Accern’s rankings:
Get Neptune Technologies & Bioressources alerts:
Neptune Technologies & Bioressources Inc. (NEPT) stock RSI touches to 33.20, it is oversold (nasdaqchronicle.com) Current Stocks are blowing up: BioLineRx Ltd. (NASDAQ:BLRX), Neptune Technologies & Bioressources Inc … (journalfinance.net) Damn Good Stocks: Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT), Retractable Technologies, Inc … (thestreetpoint.com) Some business risks from marijuana regulation changes (canadianunderwriter.ca) Neptune Announces Fourth Quarter and Year-end Results (finance.yahoo.com)
Neptune Technologies & Bioressources traded down $0.05, hitting $2.45, during midday trading on Tuesday, according to Marketbeat. 12,695 shares of the company traded hands, compared to its average volume of 262,092. Neptune Technologies & Bioressources has a 52 week low of $0.70 and a 52 week high of $3.59.
- [By Logan Wallace]
Neptune Technologies & Bioressources Inc (TSE:NEPT) insider Jacqueline Khayat sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 19th. The stock was sold at an average price of C$6.50, for a total value of C$32,500.00.
- [By Keith Speights]
Ancillary provider
Scotts Miracle-Gro (NYSE:SMG) $4.3 billion
Namaste Technologies (NASDAQOTH: NXTTF) $318 million
Kush Bottles (NASDAQOTH: KSHB) $295 million
Neptune Technologies & Bioressources (NASDAQOTH: NEPT) $220 million
CannaRoyalty (NASDAQOTH: CNNRF) $203 millionETF
- [By Todd Campbell]
After reporting that it has received a confirmation-of-readiness letter from Health Canada regarding its filing to become a licensed marijuana extracts producer under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), shares in marijuana upstart Neptune Technologies (NASDAQ:NEPT) (TSX:NEPT) are jumping 14% at 2 p.m. EDT on Monday.
Hot Low Price Stocks To Invest In Right Now: TransUnion(TRU)
Advisors’ Opinion:
- [By Max Byerly]
TransUnion (NYSE:TRU) EVP David M. Neenan sold 30,000 shares of the stock in a transaction dated Tuesday, June 5th. The stock was sold at an average price of $70.42, for a total value of $2,112,600.00. Following the completion of the sale, the executive vice president now owns 123,029 shares of the company’s stock, valued at $8,663,702.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on TransUnion (TRU)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Eagle Asset Management Inc. increased its position in shares of TransUnion (NYSE:TRU) by 11.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,432,827 shares of the business services provider’s stock after acquiring an additional 144,711 shares during the period. Eagle Asset Management Inc. owned about 0.78% of TransUnion worth $81,355,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Shane Hupp]
Get a free copy of the Zacks research report on TransUnion (TRU)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Here are some of the news headlines that may have effected Accern Sentiment’s rankings:
Get TransUnion alerts:
MIB and TransUnion Work Together to Minimize Identity Fraud in Life Insurance and Annuities (finance.yahoo.com) C2 Systems Launches Cloud-based Data Aggregation and Decision Engine (prweb.com) Insider Selling: TransUnion (TRU) EVP Sells 30,000 Shares of Stock (americanbankingnews.com) TransUnion (TRU) Expected to Post Quarterly Sales of $538.48 Million (americanbankingnews.com) TransUnion to Present at William Blair Growth Stock Conference (finance.yahoo.com)
A number of research firms have commented on TRU. Zacks Investment Research upgraded TransUnion from a “hold” rating to a “buy” rating and set a $75.00 price target on the stock in a research note on Tuesday, April 24th. Robert W. Baird upped their price target on TransUnion from $65.00 to $74.00 and gave the stock an “outperform” rating in a research note on Monday, April 23rd. SunTrust Banks upped their price target on TransUnion from $64.00 to $78.00 and gave the stock a “buy” rating in a research note on Monday, April 23rd. Barclays upped their price objective on TransUnion from $65.00 to $75.00 and gave the stock an “overweight” rating in a research report on Monday, April 23rd. Finally, Wells Fargo & Co set a $65.00 price objective on TransUnion and gave the stock a “hold” rating in a research report on Monday, April 23rd. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $66.64.
- [By Stephan Byrd]
TransUnion (NYSE:TRU) shares reached a new 52-week high and low on Thursday . The company traded as low as $69.74 and last traded at $68.94, with a volume of 28118 shares changing hands. The stock had previously closed at $68.47.
Hot Low Price Stocks To Invest In Right Now: Lam Research Corporation(LRCX)
Advisors’ Opinion:
- [By Joseph Griffin]
Lam Research (NASDAQ:LRCX) had its price objective raised by research analysts at Deutsche Bank to $260.00 in a research report issued to clients and investors on Wednesday. The firm presently has a “buy” rating on the semiconductor company’s stock. Deutsche Bank’s target price would indicate a potential upside of 36.56% from the company’s current price.
- [By Jon C. Ogg]
Lam Research Corp. (NASDAQ: LRCX) was downgraded to Neutral from Buy and the price target was cut to $180 from $224 (versus a $155.40 close) by analyst Toshiya Hari at Goldman Sachs. The downgrade warns that semiconductor capex was going to face a larger fallout from a broad-based correction in 2019. Lam Research’s stock was trading down another 3.2% at $150.50 on Wednesday morning, and previously it had a consensus target price of $239.30. The shares are now down over 35% from the 52-week high.
- [By Garrett Baldwin]
Market fears of an escalating Middle Eastern conflict abated thanks to last week’s military strikes against the Syrian government. On Friday, April 13, U.S. forces joined the United Kingdom and France in retaliation for a chemical gas attack carried out by the Syrian government. The military exercise came at a time that tensions are also rising in the Middle East between Saudi Arabia and Iran.
Today, several members of the U.S. Federal Reserve will be speaking at events around the globe, including San Francisco Fed President John Williams and Chicago Fed Bank President Charles Evans. But no one will be more watched today than Fed Gov. Randal Quarles, who will testify before the U.S. House Financial Services Commission. Quarles will provide testimony on the central bank’s plans to regulate and oversee the financial system. Expect a wealth of questions about the Fed’s plans to raise interest rates and manage its massive balance sheet. Money Morning Liquidity Specialist Lee Adler offers you advice on how to play the Fed’s problems, right here.
Four Stocks to Watch Today: GS, NFLX, TSLA, and ROKU
Shares of Goldman Sachs Group Inc. (NYSE: GS) added 0.6% after the Wall Street bank easily topped Q1 earnings and revenue estimates. The firm reported earnings per share (EPS) of $6.95 on top of more than $10 billion in revenue. Analysts projected EPS of $5.67 on top of $8.89 billion. The investment bank hiked its quarterly dividend and said that revenue from equity trading rallied thanks to an uptick in recent market volatility.
Shares of Tesla Inc. (Nasdaq: TSLA) are flat on the news that the firm will suspend production of its Model 3 vehicles. The firm said the temporary halt in production will aim to “improve automation” and address ongoing bottlenecks in its production process.
Shares of Roku Inc. (Nasdaq: ROKU) popped more than 8.2% on news that Steven Cohen’s family office has taken a passive 5.1% stake in the company. The streaming device manufactur - [By Ethan Ryder]
Lam Research (NASDAQ: LRCX) and IHI Corp/ADR (OTCMKTS:IHICY) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.